Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 2007; Volume 320,Issue 1

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Functional Selectivity and Classical Concepts of Quantitative Pharmacology
    Jonathan D. Urban, William P. Clarke, Mark von Zastrow, David E. Nichols, Brian Kobilka, Harel Weinstein, Jonathan A. Javitch, Bryan L. Roth, Arthur Christopoulos, Patrick M. Sexton, Keith J. Miller, Michael Spedding and Richard B. Mailman
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 1-13; DOI: https://doi.org/10.1124/jpet.106.104463

BEHAVIORAL PHARMACOLOGY

  • You have access
    Inflammation-Induced Reduction of Spontaneous Activity by Adjuvant: A Novel Model to Study the Effect of Analgesics in Rats
    David J. Matson, Daniel C. Broom, Susan R. Carson, James Baldassari, John Kehne and Daniel N. Cortright
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 194-201; DOI: https://doi.org/10.1124/jpet.106.109736
  • You have access
    Effects of Salvinorin A, a κ-Opioid Hallucinogen, on a Neuroendocrine Biomarker Assay in Nonhuman Primates with High κ-Receptor Homology to Humans
    Eduardo R. Butelman, Marek Mandau, Kevin Tidgewell, Thomas E. Prisinzano, Vadim Yuferov and Mary Jeanne Kreek
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 300-306; DOI: https://doi.org/10.1124/jpet.106.112417
  • You have access
    Sex Differences in Steroid Modulation of Ethanol Withdrawal in Male and Female Rats
    P. E. Alele and L. L. Devaud
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 427-436; DOI: https://doi.org/10.1124/jpet.106.107896
  • You have access
    WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity
    Karen L. Marquis, Annmarie L. Sabb, Sheree F. Logue, Julie A. Brennan, Michael J. Piesla, Tom A. Comery, Steven M. Grauer, Charles R. Ashby, Huy Q. Nguyen, Lee A. Dawson, James E. Barrett, Gary Stack, Herbert Y. Meltzer, Boyd L. Harrison and Sharon Rosenzweig-Lipson
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 486-496; DOI: https://doi.org/10.1124/jpet.106.106989

CARDIOVASCULAR

  • You have access
    Distinct KATP Channels Mediate the Antihypertrophic Effects of Adenosine Receptor Activation in Neonatal Rat Ventricular Myocytes
    Ying Xia, Sabzali Javadov, Tracey X. Gan, Theresa Pang, Michael A. Cook and Morris Karmazyn
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 14-21; DOI: https://doi.org/10.1124/jpet.106.110494
  • You have access
    Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities
    Chris Doe, Ross Bentley, David J. Behm, Robert Lafferty, Robert Stavenger, David Jung, Mark Bamford, Terry Panchal, Eugene Grygielko, Lois L. Wright, Gary K. Smith, Zunxuan Chen, Christine Webb, Sanjay Khandekar, Tracey Yi, Robert Kirkpatrick, Edward Dul, Larry Jolivette, Joseph P. Marino, Robert Willette, Dennis Lee and Erding Hu
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 89-98; DOI: https://doi.org/10.1124/jpet.106.110635
  • You have access
    Licofelone, a Balanced Inhibitor of Cyclooxygenase and 5-Lipoxygenase, Reduces Inflammation in a Rabbit Model of Atherosclerosis
    Cristina Vidal, Almudena Gómez-Hernández, Eva Sánchez-Galán, Alejandro González, Luis Ortega, Juan Antonio Gómez-Gerique, José Tuñón and Jesús Egido
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 108-116; DOI: https://doi.org/10.1124/jpet.106.110361
  • You have access
    Cyclooxygenase, p38 Mitogen-Activated Protein Kinase (MAPK), Extracellular Signal-Regulated Kinase MAPK, Rho Kinase, and Src Mediate Hydrogen Peroxide-Induced Contraction of Rat Thoracic Aorta and Vena Cava
    Keshari Thakali, Lauren Davenport, Gregory D. Fink and Stephanie W. Watts
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 236-243; DOI: https://doi.org/10.1124/jpet.106.110650
  • You have access
    The Nitric Oxide-Donating Pravastatin Derivative, NCX 6550 [(1S-[1α(βS*, δS*), 2α, 6α, 8β-(R*), 8aα]]-1,2,6,7,8,8a-Hexahydro-β, δ, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic Acid 4-(Nitrooxy)butyl Ester)], Reduces Splenocyte Adhesion and Reactive Oxygen Species Generation in Normal and Atherosclerotic Mice
    G. Dever, C. M. Spickett, S. Kennedy, C. Rush, G. Tennant, A. Monopoli and C. L. Wainwright
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 419-426; DOI: https://doi.org/10.1124/jpet.106.109298

CELLULAR AND MOLECULAR

  • You have access
    Comparative Studies of Anthraquinone- and Anthracene-Tetraamines as Blockers of N-Methyl-d-aspartate Receptors
    Lihua Jin, Hiromi Sugiyama, Miki Takigawa, Daisuke Katagiri, Hideyuki Tomitori, Kazuhiro Nishimura, Navneet Kaur, Otto Phanstiel, Mariko Kitajima, Hiromitsu Takayama, Tadashi Okawara, Keith Williams, Keiko Kashiwagi and Kazuei Igarashi
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 47-55; DOI: https://doi.org/10.1124/jpet.106.110528
  • You have access
    Complete Inhibition of P-glycoprotein by Simultaneous Treatment with a Distinct Class of Modulators and the UIC2 Monoclonal Antibody
    Katalin Goda, Ferenc Fenyvesi, Zsolt Bacsó, Henrietta Nagy, Teréz Márián, Attila Megyeri, Zoltán Krasznai, István Juhász, Miklós Vecsernyés and Gábor Szabó
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 81-88; DOI: https://doi.org/10.1124/jpet.106.110155
  • You have access
    A Comparison of the Antagonist Affinities for the Gi- and Gs-Coupled States of the Human Adenosine A1-Receptor
    Jillian G. Baker and Stephen J. Hill
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 218-228; DOI: https://doi.org/10.1124/jpet.106.113589
  • You have access
    Mechanisms Linking Adenosine A1 Receptors and Extracellular Signal-Regulated Kinase 1/2 Activation in Human Trabecular Meshwork Cells
    S. Husain, T. W. Shearer and C. E. Crosson
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 258-265; DOI: https://doi.org/10.1124/jpet.106.110981
  • You have access
    Comparison of Signaling Pathways Activated by the Relaxin Family Peptide Receptors, RXFP1 and RXFP2, Using Reporter Genes
    Michelle L. Halls, Ross A. D. Bathgate and Roger J. Summers
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 281-290; DOI: https://doi.org/10.1124/jpet.106.113225
  • You have access
    Inhibition of Human Preadipocyte Proteasomal Activity by HIV Protease Inhibitors or Specific Inhibitor Lactacystin Leads to a Defect in Adipogenesis, Which Involves Matrix Metalloproteinase-9
    Sandra De Barros, Alexia Zakaroff-Girard, Max Lafontan, Jean Galitzky and Virginie Bourlier
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 291-299; DOI: https://doi.org/10.1124/jpet.106.111849
  • You have access
    Ca2+-Calmodulin and Janus Kinase 2 Are Required for Activation of Sodium-Proton Exchange by the Gi-Coupled 5-Hydroxytryptamine1a Receptor
    Justin H. Turner, Maria N. Garnovskaya, Sonya D. Coaxum, Tamara M. Vlasova, Margarita Yakutovich, David M. Lefler and John R. Raymond
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 314-322; DOI: https://doi.org/10.1124/jpet.106.112581
  • You have access
    Lack of the Aryl Hydrocarbon Receptor Leads to Impaired Activation of AKT/Protein Kinase B and Enhanced Sensitivity to Apoptosis Induced via the Intrinsic Pathway
    Ran Wu, Li Zhang, Martin S. Hoagland and Hollie I. Swanson
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 448-457; DOI: https://doi.org/10.1124/jpet.106.111773

ENDOCRINE AND DIABETES

  • You have access
    Desoxyrhaponticin (3,5-Dihydroxy-4′-methoxystilbene 3-O-β-d-glucoside) Inhibits Glucose Uptake in the Intestine and Kidney: In Vitro and in Vivo Studies
    Jian Mei Li, Chun Tao Che, Clara B. S. Lau, Po Sing Leung and Christopher H. K. Cheng
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 38-46; DOI: https://doi.org/10.1124/jpet.106.111526
  • You have access
    Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level
    Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura, Masahiro Hiratochi, Fumiaki Itoh, Yoshimitsu Komatsu, Hideki Fujikura and Masayuki Isaji
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 323-330; DOI: https://doi.org/10.1124/jpet.106.110296
  • You have access
    Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats
    M. J. Stevens, F. Li, V. R. Drel, O. I. Abatan, H. Kim, D. Burnett, D. Larkin and I. G. Obrosova
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 458-464; DOI: https://doi.org/10.1124/jpet.106.109702
  • You have access
    The Thyroid Disruptor 1,1,1-Trichloro-2,2-Bis(p-Chlorophenyl)-Ethane Appears to Be an Uncompetitive Inverse Agonist for the Thyrotropin Receptor
    Mario Rossi, Antonio Dimida, Maria Teresa Dell'anno, Maria Letizia Trincavelli, Patrizia Agretti, Franco Giorgi, Giovanni U. Corsini, Aldo Pinchera, Paolo Vitti, Massimo Tonacchera and Roberto Maggio
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 465-474; DOI: https://doi.org/10.1124/jpet.106.113613

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    The Prevention of Colitis by E Prostanoid Receptor 4 Agonist through Enhancement of Epithelium Survival and Regeneration
    Guang-Liang Jiang, Amelia Nieves, Wha Bin Im, David W. Old, Danny T. Dinh and Larry Wheeler
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 22-28; DOI: https://doi.org/10.1124/jpet.106.111146
  • You have access
    The Extracellular cAMP-Adenosine Pathway Significantly Contributes to the in Vivo Production of Adenosine
    Edwin K. Jackson, Zaichuan Mi and Raghvendra K. Dubey
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 117-123; DOI: https://doi.org/10.1124/jpet.106.112748
  • You have access
    The Nuclear Receptor Constitutively Active/Androstane Receptor Regulates Type 1 Deiodinase and Thyroid Hormone Activity in the Regenerating Mouse Liver
    Eric S. Tien, Kenji Matsui, Rick Moore and Masahiko Negishi
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 307-313; DOI: https://doi.org/10.1124/jpet.106.112706

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    A p38α Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss
    Keith L. Kirkwood, Fei Li, Jill E. Rogers, Jodie Otremba, Derek D. Coatney, Jaclynn M. Kreider, Nisha J. D'Silva, Sarvajit Chakravarty, Sundeep Dugar, Linda S. Higgins, Andrew A. Protter and Satyanarayana Medicherla
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 56-63; DOI: https://doi.org/10.1124/jpet.106.112466
  • You have access
    Agonist and Antagonist Effects of 15R-Prostaglandin (PG) D2 and 11-Methylene-PGD2 on Human Eosinophils and Basophils
    Chantal Cossette, Sinead E. Walsh, Seongjin Kim, Gue-Jae Lee, John A. Lawson, Sophie Bellone, Joshua Rokach and William S. Powell
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 173-179; DOI: https://doi.org/10.1124/jpet.106.111062

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

  • You have access
    The Contribution of Intestinal UDP-Glucuronosyltransferases in Modulating 7-Ethyl-10-hydroxy-camptothecin (SN-38)-Induced Gastrointestinal Toxicity in Rats
    Melanie N. Tallman, Kristini K. Miles, Fay K. Kessler, Judith N. Nielsen, Xianbin Tian, Joseph K. Ritter and Philip C. Smith
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 29-37; DOI: https://doi.org/10.1124/jpet.106.110924
  • You have access
    Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers
    Stephanie R. Faucette, Tong-Cun Zhang, Rick Moore, Tatsuya Sueyoshi, Curtis J. Omiecinski, Edward L. LeCluyse, Masahiko Negishi and Hongbing Wang
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 72-80; DOI: https://doi.org/10.1124/jpet.106.112136
  • You have access
    Marked Strain Differences in the Pharmacokinetics of an α4β1 Integrin Antagonist, 4-[1-[3-Chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]-methoxybenzoic Acid (D01-4582), in Sprague-Dawley Rats Are Associated with Albumin Genetic Polymorphism
    Takashi Ito, Masayuki Takahashi, Kenichi Sudo and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 124-132; DOI: https://doi.org/10.1124/jpet.106.111948
  • You have access
    Bias in Estimation of Transporter Kinetic Parameters from Overexpression Systems: Interplay of Transporter Expression Level and Substrate Affinity
    Anand Balakrishnan, Naissan Hussainzada, Pablo Gonzalez, Marival Bermejo, Peter W. Swaan and James E. Polli
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 133-144; DOI: https://doi.org/10.1124/jpet.106.107433
  • You have access
    Concentration-Dependent Mode of Interaction of Angiotensin II Receptor Blockers with Uric Acid Transporter
    Takashi Iwanaga, Masanobu Sato, Tomoji Maeda, Toshio Ogihara and Ikumi Tamai
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 211-217; DOI: https://doi.org/10.1124/jpet.106.112755
  • You have access
    Interaction of Nonsteroidal Anti-Inflammatory Drugs with Multidrug Resistance Protein (MRP) 2/ABCC2- and MRP4/ABCC4-Mediated Methotrexate Transport
    Azza A. K. El-Sheikh, Jeroen J. M. W. van den Heuvel, Jan B. Koenderink and Frans G. M. Russel
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 229-235; DOI: https://doi.org/10.1124/jpet.106.110379
  • You have access
    Identification and Functional Analysis of Common Human Flavin-Containing Monooxygenase 3 Genetic Variants
    Sevasti B. Koukouritaki, Mark T. Poch, Marilyn C. Henderson, Lisbeth K. Siddens, Sharon K. Krueger, Jonathan E. VanDyke, David E. Williams, Nicholas M. Pajewski, Tao Wang and Ronald N. Hines
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 266-273; DOI: https://doi.org/10.1124/jpet.106.112268
  • You have access
    Valproic Acid Is Not a Substrate for P-glycoprotein or Multidrug Resistance Proteins 1 and 2 in a Number of in Vitro and in Vivo Transport Assays
    Steffen Baltes, Maren Fedrowitz, Carlos Luna Tortós, Heidrun Potschka and Wolfgang Löscher
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 331-343; DOI: https://doi.org/10.1124/jpet.106.102491
  • You have access
    Transport, Metabolism, and in Vivo Population Pharmacokinetics of the Chloro Benztropine Analogs, a Class of Compounds Extensively Evaluated in Animal Models of Drug Abuse
    Ahmed A. Othman, Shariq A. Syed, Amy H. Newman and Natalie D. Eddington
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 344-353; DOI: https://doi.org/10.1124/jpet.106.111245

NEUROPHARMACOLOGY

  • You have access
    Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons
    Simon Akerman, Philip R. Holland and Peter J. Goadsby
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 64-71; DOI: https://doi.org/10.1124/jpet.106.106971
  • You have access
    A Chimeric Human/Murine Anticocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Mice
    Andrew B. Norman, Michael R. Tabet, Mantana K. Norman, William R. Buesing, Amadeo J. Pesce and William J. Ball
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 145-153; DOI: https://doi.org/10.1124/jpet.106.111781
  • You have access
    Anticonvulsants for Nerve Agent-Induced Seizures: The Influence of the Therapeutic Dose of Atropine
    Tsung-Ming Shih, Tami C. Rowland and John H. McDonough
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 154-161; DOI: https://doi.org/10.1124/jpet.106.111252
  • You have access
    4-Aminopyridine Prevents the Conformational Changes Associated with P/C-Type Inactivation in Shaker Channels
    Thomas W. Claydon, Moni Vaid, Saman Rezazadeh, Steven J. Kehl and David Fedida
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 162-172; DOI: https://doi.org/10.1124/jpet.106.110411
  • You have access
    Extended Access to Nicotine Self-Administration Leads to Dependence: Circadian Measures, Withdrawal Measures, and Extinction Behavior in Rats
    Laura E. O'Dell, Scott A. Chen, Ron T. Smith, Sheila E. Specio, Robert L. Balster, Neil E. Paterson, Athina Markou, Eric P. Zorrilla and George F. Koob
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 180-193; DOI: https://doi.org/10.1124/jpet.106.105270
  • You have access
    Protein Kinase A Activation Down-Regulates, Whereas Extracellular Signal-Regulated Kinase Activation Up-Regulates σ-1 Receptors in B-104 Cells: Implication for Neuroplasticity
    Gianfrancesco Cormaci, Tomohisa Mori, Teruo Hayashi and Tsung-Ping Su
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 202-210; DOI: https://doi.org/10.1124/jpet.106.108415
  • You have access
    Nicotinic Regulation of Calcium/Calmodulin-Dependent Protein Kinase II Activation in the Spinal Cord
    M. I. Damaj
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 244-249; DOI: https://doi.org/10.1124/jpet.106.111336
  • You have access
    Inhibition of Nicotine Metabolism by Methoxysalen: Pharmacokinetic and Pharmacological Studies in Mice
    M. I. Damaj, E. C. K. Siu, E. M. Sellers, R. F. Tyndale and B. R. Martin
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 250-257; DOI: https://doi.org/10.1124/jpet.106.111237
  • You have access
    Use-Dependent Block by Lidocaine but Not Amitriptyline Is More Pronounced in Tetrodotoxin (TTX)-Resistant Nav1.8 Than in TTX-Sensitive Na+ Channels
    Andreas Leffler, Anne Reiprich, Durga P. Mohapatra and Carla Nau
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 354-364; DOI: https://doi.org/10.1124/jpet.106.109025
  • You have access
    BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
    X. Ligneau, D. Perrin, L. Landais, J.-C. Camelin, T. P. G. Calmels, I. Berrebi-Bertrand, J.-M. Lecomte, R. Parmentier, C. Anaclet, J.-S. Lin, V. Bertaina-Anglade, C. Drieu la Rochelle, F. d'Aniello, A. Rouleau, F. Gbahou, J.-M. Arrang, C. R. Ganellin, H. Stark, W. Schunack and J.-C. Schwartz
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 365-375; DOI: https://doi.org/10.1124/jpet.106.111039
  • You have access
    D2-Like Dopamine Receptors Depolarize Dorsal Raphe Serotonin Neurons through the Activation of Nonselective Cationic Conductance
    Teresa K. Aman, Roh-Yu Shen and Samir Haj-Dahmane
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 376-385; DOI: https://doi.org/10.1124/jpet.106.111690
  • You have access
    The Experimental Alzheimer's Disease Drug Posiphen [(+)-Phenserine] Lowers Amyloid-β Peptide Levels in Cell Culture and Mice
    Debomoy K. Lahiri, DeMao Chen, Bryan Maloney, Harold W. Holloway, Qian-sheng Yu, Tada Utsuki, Tony Giordano, Kumar Sambamurti and Nigel H. Greig
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 386-396; DOI: https://doi.org/10.1124/jpet.106.112102
  • You have access
    Selective Activation of Group III Metabotropic Glutamate Receptors by l-(+)-2-Amino-4-phosphonobutryic Acid Protects the Nigrostriatal System against 6-Hydroxydopamine Toxicity in Vivo
    Anthony C. Vernon, Virginia Zbarsky, Krishna P. Datla, David T. Dexter and Martin J. Croucher
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 397-409; DOI: https://doi.org/10.1124/jpet.106.108159
  • You have access
    Two Protein Trafficking Processes at Motor Nerve Endings Unveiled by Botulinum Neurotoxin E
    Gary Lawrence, Jiafu Wang, C. K. N. Kwo Chion, K. Roger Aoki and J. Oliver Dolly
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 410-418; DOI: https://doi.org/10.1124/jpet.106.108829
  • You have access
    Group III Metabotropic Glutamate Receptor Agonists Selectively Suppress Excitatory Synaptic Currents in the Rat Prefrontal Cortex Induced by 5-Hydroxytryptamine2A Receptor Activation
    Ce Zhang and Gerard J. Marek
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 437-447; DOI: https://doi.org/10.1124/jpet.106.107490
  • You have access
    Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1
    David B. Wainscott, Sheila P. Little, Tinggui Yin, Yuan Tu, Vincent P. Rocco, John X. He and David L. Nelson
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 475-485; DOI: https://doi.org/10.1124/jpet.106.112532

TOXICOLOGY

  • You have access
    Comparison of S-Adenosyl-l-methionine and N-Acetylcysteine Protective Effects on Acetaminophen Hepatic Toxicity
    Marcus V. Terneus, K. Kelley Kiningham, A. Betts Carpenter, Sarah B. Sullivan and Monica A. Valentovic
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 99-107; DOI: https://doi.org/10.1124/jpet.106.111872
  • You have access
    Roles of Norepinephrine, Free Fatty Acids, Thyroid Status, and Skeletal Muscle Uncoupling Protein 3 Expression in Sympathomimetic-Induced Thermogenesis
    Jon E. Sprague, Xianmei Yang, Joni Sommers, Tracy L. Gilman and Edward M. Mills
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 274-280; DOI: https://doi.org/10.1124/jpet.106.107755

Errata

  • You have access
    Correction to “In Vitro Metabolism of (Nitroxy)butyl Ester Nitric Oxide-Releasing Compounds: Comparison with Glyceryl Trinitrate”
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 497;
  • You have access
    Correction to “NAP Enhances Neurodevelopment of Newborn E-Deficient Mice Subjected to Hypoxia”
    Journal of Pharmacology and Experimental Therapeutics January 2007, 320 (1) 498;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 320 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 320, Issue 1
1 Jan 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • ENDOCRINE AND DIABETES
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
  • METABOLISM, TRANSPORT, AND PHARMACOGENOMICS
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Errata
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics